CAR T-cell therapy trial yields early promise for lymphoma andleukemia patients

In a phase I/IIa trial, third-generation CD19 CAR T-cell therapy combined withchemotherapy pretreatment resulted in complete response in some lymphoma and leukemiapatients, according to data… Source link